Cargando…
Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties. However, most of the studies to evaluate therapeutic efficacy of metformin have been on primary cancer. No information is available whether metformin could be effectively used f...
Autores principales: | Nangia-Makker, Pratima, Yu, Yingjie, Vasudevan, Anita, Farhana, Lulu, Rajendra, Sindhu G., Levi, Edi, Majumdar, Adhip P. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896365/ https://www.ncbi.nlm.nih.gov/pubmed/24465408 http://dx.doi.org/10.1371/journal.pone.0084369 |
Ejemplares similares
-
miR-21 and miR-145 cooperation in regulation of colon cancer stem cells
por: Yu, Yingjie, et al.
Publicado: (2015) -
Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice
por: Farhana, Lulu, et al.
Publicado: (2020) -
A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells
por: Yu, Yingjie, et al.
Publicado: (2017) -
Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells
por: Goyal, Sachin, et al.
Publicado: (2016) -
Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans
por: Farhana, Lulu, et al.
Publicado: (2018)